CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Amwill Health Care Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Amwill Health Care Ltd
Chamrajpet
3rd Cross, No. 157, 1st Floor, 2nd Main
Phone: +91 8026605825p:+91 8026605825 BANGALORE, 560018  India Ticker: 544353544353
Business Summary
Amwill Health Care Limited is an India-based derma-cosmetic development company. The core focus of the Company is the development of problem-solving dermatological, cosmeceutical, and aesthetical products. The product portfolio of the Company is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific dermatological problems. It has a portfolio of products across various problem areas including hair care, skin care and lip care. Its product categories include anti acne, dry skin, anti-fungal, anti-histaminic, anti-perspirant, anti-biotics, skin lightening, special haircare, vitiligo, sunscreen, antioxidants, anti-scabies, and others. The products developed by the Company include Decomedo Gel, Pustulex Gel, Avertage Pro Cream, Histocross 180 Tabs, Depimed Ultra Cream 30 Gm, Ultra Kromaglo Effervescent Tablets, Depimed Tx Tablets, and Ultra Kromaglo Cream, among others.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024-----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2844 Perfumes, cosmetics, and other toilet preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Managing Director, Executive Chairman of the Board TarunGandhi 39 1/27/2024 1/27/2024
Chief Financial Officer SharanyaNagaraj 27 1/25/2024 4/12/2023
Compliance Officer, Company Secretary SapnaParmar 36 1/25/2024 1/25/2024
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 84 (As of 9/30/2024)
Outstanding Shares: 20,003,600 (As of 2/12/2025)
Shareholders: 7
Stock Exchange: BOM


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, March 11, 2025